Exceptional Clinical Benefits for Patients and Physicians Confirmed Data Presented at the European Society of Cardiology Annual Congress ST. LOUIS, Sept. 8 (HSMN NewsFeed) — Stereotaxis, Inc. (Nasdaq:STXS ) highlighted significant new additions t…
Devices, Cardiology
Stereotaxis, Niobe, Magnetic Navigation, ventricular tachycardia

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Stereotaxis Announces First-Ever, Prospective, Comparative Clinical Trial Outcome for VT Patients”
Leave a Comment